Wolf Greenfield Earns National Recognition in IAM Patent 1000 2026 Rankings
Wolf Greenfield has once again earned top honors in the IAM Patent 1000: The World’s Leading Patent Professionals, recognized nationally for its excellence.
Wolf Greenfield has once again earned top honors in the IAM Patent 1000: The World’s Leading Patent Professionals, recognized nationally for its excellence.
Wolf Greenfield was named the #1 Midsize Law Firm in Boston in the 2026–2027 Vault Law Firm Rankings, topping Vault’s newly launched Best Midsize Law Firms by Region list.
Kevin MacDonald was quoted by Life Sciences Intellectual Property Review (LSIPR) in an article titled “Argentina’s Patent Reset: Why Pharma Can No Longer Ignore Latin America's Second-Largest Market.”...
Hunter Baker, chair of Wolf Greenfield’s Pharmaceutical Practice, has been named “Patent Prosecutor of the Year – Northeast” at the 2026 Managing IP Americas Awards.
Wolf Greenfield has been recognized as one of the top performing and most active law firms for biotech patent prosecution in the 2026 LexDana Patent Intelligence Rankings.
Wolf Greenfield has been recognized as one of the top performing and most active law firms for high-tech patent prosecution in the 2026 LexDana Patent Intelligence Rankings.
Oona Johnstone, chair of Wolf Greenfield’s Prosecution & Counseling Department, has been selected as a finalist in the Inspiring Woman of the Year category at the LSPN Awards USA 2026. These award...
Heather DiPietrantonio, a shareholder in Wolf Greenfield’s Biotechnology Practice, has been selected as a finalist in the Patent Prosecutor of the Year category at the LSPN Awards USA 2026. These awar...
Phil Hamzik, a shareholder in Wolf Greenfield’s Pharmaceutical Practice, has been selected as a finalist in the Rising Star of the Year category at the LSPN Awards USA 2026. These awards recognize exc...
Wolf Greenfield has been named a finalist for three awards at the LSPN Awards USA 2026. These awards recognize excellence, innovation, and leadership in life sciences intellectual property.
Four Wolf Greenfield shareholders have been named to the Legal 500 City Elite lists, recognizing leading intellectual property practitioners in key US markets.
Dan Young, a shareholder in Wolf Greenfield’s Biotechnology Practice, has been nationally recognized for his non-contentious work in the World IP Review (WIPR) USA Patents 2025 rankings.